Clinical Trial Update: Comparative Evaluation of Vitamin C and Injectable-platelet Rich Fibrin in the Management of Thin Gingival Phenotype [Phase 4]

View source ↗

Summary

This Phase 4 trial compares Vitamin C with injectable-platelet rich fibrin for managing thin gingival phenotype, but the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thin Gingival Biotype

Drugs mentioned

• Injectable Platelet Rich Fibrin (platelet-rich fibrin)
• Vitamin C (ascorbic acid)

Snippet

Sponsor: Cairo University | Conditions: Thin Gingival Biotype | Phase 4 | Status: UNKNOWN